| Overview |
| bs-6309r |
| IL-6 Polyclonal Antibody |
| WB, IHC-P, IF(IHC-P) |
| Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from mouse IL-6 |
| Polyclonal |
| #REF! |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20C for 12 months. |
| Target |
| 16193 |
| Interleukin BSF 2; B cell dferentiation factor; B cell stimulatory factor 2; BSF 2; BSF2; CDF; CTL dferentiation factor; Cytotoxic T cell dferentiation factor; Hepatocyte stimulating factor; HGF; HPGF; HSF; Hybridoma growth factor; Hybridoma plasmacytoma growth factor; NB2; IL 6; IL6 protein; Interferon beta 2; Interleukin 6 interferon beta 2; Interleukin-6; Interleukin6; IL6_HUMAN. |
| IL6 is reported to be produced by fibroblasts, activated T cells, activated monocytes or macrophages and endothelial cells. It acts upon a variety of cells including fibroblasts, myeloid progenitor cells, T cells, B cells and hepatocytes. In addition, IL6 appears to interact with IL2 in the proliferation of T lymphocytes. IL6 potentiates the proliferative effect of IL3 on multipotential hematopoietic progenitors. |
| Application Dilution |
| WB |
|
| IHC-P |
|
| IF(IHC-P) |
|